Novonesis expects 7-8% full-year organic sales growth after reporting strong third-quarter results.

Novonesis reported robust results for the third quarter and is now anticipating full-year organic sales growth between 7% and 8%. The company’s performance reflects its strong market position and effective strategies. This update indicates confidence in continued growth and stability moving forward.

November 07, 2024
3 Articles